Search Results - "Argulian, Anna"

Targeting Innate Immunity in Cancer Therapy by Rameshbabu, Srikrishnan, Labadie, Brian W, Argulian, Anna, Patnaik, Akash

“…The majority of current cancer immunotherapy strategies target and potentiate antitumor adaptive immune responses. Unfortunately, the efficacy of these…”
Get full text

1537 Androgen blockade primes NLRP3 inflammasome in macrophages to induce tumor cell phagocytosis by Chaudagar, Kiranj, Rameshbabu, Srikrishnan, Mei, Shenglin, Hirz, Taghreed, Xia, Zheng, Hu, Ya-Mei, Argulian, Anna, Labadie, Brian, Desai, Kunal, Grimaldo, Sammy, Kahramangil, Doga, Nair, Rishikesh, DSouza, Sabina, Zhou, Dylan, Shafran, Jordan, Sykes, David, Moran, Amy, Patnaik, Akash

“…BackgroundWhile immune-based therapies induce durable remissions in subsets of patients across a wide range of malignancies, efficacy in metastatic…”
Get full text

Black patient representation in anti-cancer drug development by Karol, Alexander B., Paredes, Rodrigo, Fujiwara, Yu, Argulian, Anna, Joshi, Himanshu, Galsky, Matt D.

“…e13680 Background: Black patient enrollment in cancer clinical trials is critical to improving the generalizability of trial results and advancing an…”
Get full text

Heterogeneity in Methods of Estimating Kidney Function for Cancer Clinical Trial Eligibility by Karol, Alexander B, Paredes, Rodrigo, Fujiwara, Yu, Argulian, Anna, Joshi, Himanshu, Abramson, Matthew, Galsky, Matthew D

“…This cross-sectional study examined the kidney-function eligibility criteria for patients for enrollment in contemporary cancer clinical trials…”
Get full text

Abstract 5270: Androgen receptor blockade in macrophages primes NLRP3 inflammasome-mediated phagocytosis and tumor clearance in advanced prostate cancer by Chaudagar, Kiranj, Rameshbabu, Srikrishnan, Mei, Shenglin, Hirz, Taghreed, Hu, Ya-Mei, Argulian, Anna, Labadie, Brian, Desai, Kunal, Grimaldo, Sam, Kahramangil, Doga, Nair, Rishikesh, DSouza, Sabina, Zhou, Dylan, Chen, Raymond, Shafran, Jordan, Loyd, Mayme, Xia, Zheng, Sykes, David, Moran, Amy, Patnaik, Akash

“…Abstract Immune-based therapies induce durable remissions in subsets of patients across multiple malignancies. However, there is limited efficacy of…”
Get full text